HELSINKI (AP) — Many Finnish pharmacies ran out of iodine tablets Wednesday, a day after the Nordic country’s health ministry recommended that households buy a single dose in a case of a radiation emergency amid increasing fears of a nuclear event due to Russia’s war in Ukraine.
“An accident at a nuclear power plant could release radioactive iodine into the environment, which could build up in the thyroid gland,” the Finnish Ministry of Social Affairs and Health said Tuesday.
Pharmacies in many locations in Finland reported Wednesday they had run out of iodine tablets as citizens rushed to purchase the medicine. Drug wholesale also said their were stockpiles emptied out.
The ministry said the iodine tablet recommendation is limited to those aged 3-40 because of the potential risks that radiation exposure poses to that age group.
The ministry didn’t mention Russia’s war in Ukraine and didn’t disclose where such nuclear accidents could potentially take place. It only said it had revised guidelines on the use of iodine tablets to match the latest iodine recommendations set by the World Health Organization.
However, Petteri Tiippana, director general of the Radiation and Nuclear Safety Authority of Finland, told the Finnish newspaper Ilta-Sanomat there was a link between the update and the situation in Ukraine.
“Yes, the war in Ukraine has influenced the updating of the instructions,” Tiippana told the newspaper. ”People must have up-to-date instructions should such a need arise.”
In a case of a radiation emergency, sheltering indoors is the main way for people to protect themselves from hazardous radiation, the Finnish health ministry stressed.
___
Follow the AP’s coverage of the war at https://apnews.com/hub/russia-ukraine
Before you consider Citigroup, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Citigroup wasn't on the list.
While Citigroup currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.